Clinically significant portal hypertension (CSPH) on early-stage HCC following hepatectomy: What's the impact?

MLA

Xia, Feng, et al. “Clinically Significant Portal Hypertension (CSPH) on Early-Stage HCC Following Hepatectomy: What’s the Impact?” European Journal of Surgical Oncology : The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, vol. 49, no. 4, Apr. 2023, pp. 771–79. EBSCOhost, https://doi.org/10.1016/j.ejso.2022.11.005.

APA

Xia, F., Huang, Z., Zhang, Q., Ndhlovu, E., Chen, X., Zhang, B., & Zhu, P. (2023). Clinically significant portal hypertension (CSPH) on early-stage HCC following hepatectomy: What’s the impact? European Journal of Surgical Oncology : The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 49(4), 771–779. https://doi.org/10.1016/j.ejso.2022.11.005

Chicago

Xia, Feng, Zhiyuan Huang, Qiao Zhang, Elijah Ndhlovu, Xiaoping Chen, Bixiang Zhang, and Peng Zhu. 2023. “Clinically Significant Portal Hypertension (CSPH) on Early-Stage HCC Following Hepatectomy: What’s the Impact?” European Journal of Surgical Oncology : The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 49 (4): 771–79. doi:10.1016/j.ejso.2022.11.005.